[Cellar senescence and tumor]

Nian-Xi Zhao1, Shi-Xin Lu

  • 1Department of Etiology and Carcinogenesis, Cancer Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P.R.China.

Insights

Cellular senescence, a state of irreversible cell cycle arrest, is a fundamental biological process. Understanding senescence mechanisms is crucial for developing novel cancer therapies.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Cellular senescence is a state where normal cells permanently exit the cell cycle.
  • This process is a fundamental aspect of normal cell biology with few exceptions.
  • Senescence involves significant alterations in gene expression and cellular pathways.

Purpose of the Study:

  • To summarize the molecular changes associated with cellular senescence.
  • To explore the connection between senescence, tumorigenesis, and cancer therapy.
  • To highlight the need for further research in diverse cell types.

Main Methods:

  • Review of molecular analyses identifying gene expression changes during senescence.
  • Examination of alterations in transcriptional regulators, CDK inhibitors, and telomere dynamics.
  • Analysis of existing findings linking senescence to cancer development and treatment.

Main Results:

  • Senescence involves repression of positive transcriptional regulators.
  • Over-expression of cyclin-dependent kinase (CDK) inhibitors is observed.
  • Changes in telomere length and telomerase activity are characteristic of senescence.

Conclusions:

  • Cellular senescence is intrinsically linked to both cancer development (tumorigenesis) and cancer treatment (tumor therapy).
  • Further studies using cell types beyond fibroblasts are needed to fully elucidate senescence's role in tumorigenesis.
  • Investigating senescence may offer novel therapeutic strategies for cancer repression.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...